OAG
Orbis Allan Gray’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $692M | Buy |
2,121,412
+486,489
| +30% | +$159M | 3.36% | 6 |
|
|
2025
Q1 | $441M | Buy |
1,634,923
+162,121
| +11% | +$43.8M | 2.53% | 11 |
|
|
2024
Q4 | $347M | Buy |
1,472,802
+204,690
| +16% | +$48.2M | 1.86% | 18 |
|
|
2024
Q3 | $349M | Buy |
1,268,112
+547,059
| +76% | +$150M | 1.85% | 19 |
|
|
2024
Q2 | $175M | Buy |
+721,053
| New | +$175M | 1.09% | 33 |
|
|
2023
Q4 | – | Sell |
-38,189
| Closed | -$6.76M | – | 74 |
|
|
2023
Q3 | $6.76M | Buy |
+38,189
| New | +$6.76M | 0.05% | 71 |
|